Lou Koller, the charismatic frontman of the New York hardcore outfit Sick of It All, died on June 28, 2024, at the age of 59 after a battle with adenocarcinoma, a form of cancer that originates in glandular epithelial cells. In a June 2024 post to his followers, Koller revealed that doctors had found a tumor in his esophagus that had spread into his stomach, forcing him to halt touring for treatment.
The band announced the loss on Friday via a social‑media message that read, “It’s with unbelievable sadness that we announce to our worldwide hardcore family the passing of our brother Lou Koller. The level of loss that we feel at this time is overwhelming.” The statement noted that 2024 would have marked the 40th anniversary of Sick of It All’s formation.
Lou’s bandmates praised his camaraderie, commitment and enthusiasm, describing him as a beloved friend and an iconic frontman who could lift the spirits of crowds with a smile and a sarcastic quip. They added that he won people over wherever they performed, “from every culture and every corner of the world.”
In the statement, the band also thanked those who had contributed to Lou’s medical fund during his fight with the disease, writing, “His battle is over now and he can finally rest. Hopefully he can somehow still see and feel the beautiful, positive mark he left on the world.”
Lou Koller and his brother Pete Koller founded Sick of It All in 1986 in Queens, New York, along with drummer Armand Majidi. The group released its debut album, Blood, Sweat and No Tears, in 1989 and became a staple of the New York hardcore scene through relentless touring. Bassist Craig Setari joined in 1993, and the band’s most recent album, Wake the Sleeping Dragon!, came out in 2018, after which they continued to perform worldwide.
Adenocarcinoma is the most common form of cancers in several organs, including the lungs, colon, rectum, prostate, breast, pancreas, esophagus, and stomach. Symptoms vary by location and stage, and early detection is often difficult; diagnosis typically involves a biopsy to examine tissue samples. The Cancer Council Australia notes that adenocarcinomas can develop in many glandular tissues, with the most frequent sites being the bowel, kidney, prostate, stomach, breast, and lungs.










